[go: up one dir, main page]

NO178108C - Salter av hydrazoner, farmasöytiske preparater inneholdende saltene samt anvendelse av saltene - Google Patents

Salter av hydrazoner, farmasöytiske preparater inneholdende saltene samt anvendelse av saltene

Info

Publication number
NO178108C
NO178108C NO924001A NO924001A NO178108C NO 178108 C NO178108 C NO 178108C NO 924001 A NO924001 A NO 924001A NO 924001 A NO924001 A NO 924001A NO 178108 C NO178108 C NO 178108C
Authority
NO
Norway
Prior art keywords
acids
acid
unsubstituted
substituted
salts
Prior art date
Application number
NO924001A
Other languages
English (en)
Norwegian (no)
Other versions
NO178108B (no
NO924001D0 (no
NO924001L (no
Inventor
Jaroslav Stanek
Jorg Frei
Giorgio Caravatti
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of NO924001D0 publication Critical patent/NO924001D0/no
Publication of NO924001L publication Critical patent/NO924001L/no
Publication of NO178108B publication Critical patent/NO178108B/no
Publication of NO178108C publication Critical patent/NO178108C/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/06Esters of carbamic acids
    • C07C271/08Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
    • C07C271/10Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C271/18Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of hydrocarbon radicals substituted by doubly-bound oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C281/00Derivatives of carbonic acid containing functional groups covered by groups C07C269/00 - C07C279/00 in which at least one nitrogen atom of these functional groups is further bound to another nitrogen atom not being part of a nitro or nitroso group
    • C07C281/16Compounds containing any of the groups, e.g. aminoguanidine
    • C07C281/18Compounds containing any of the groups, e.g. aminoguanidine the other nitrogen atom being further doubly-bound to a carbon atom, e.g. guanylhydrazones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/155Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/02Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/02Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/06Antimalarials
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/04Antineoplastic agents specific for metastasis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C249/00Preparation of compounds containing nitrogen atoms doubly-bound to a carbon skeleton
    • C07C249/16Preparation of compounds containing nitrogen atoms doubly-bound to a carbon skeleton of hydrazones
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00Systems containing two condensed rings
    • C07C2602/02Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/04One of the condensed rings being a six-membered aromatic ring
    • C07C2602/06One of the condensed rings being a six-membered aromatic ring the other ring being four-membered
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00Systems containing two condensed rings
    • C07C2602/02Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/04One of the condensed rings being a six-membered aromatic ring
    • C07C2602/08One of the condensed rings being a six-membered aromatic ring the other ring being five-membered, e.g. indane

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Photoreceptors In Electrophotography (AREA)
  • Detergent Compositions (AREA)
  • Cereal-Derived Products (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Cosmetics (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Non-Silver Salt Photosensitive Materials And Non-Silver Salt Photography (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
NO924001A 1991-10-16 1992-10-15 Salter av hydrazoner, farmasöytiske preparater inneholdende saltene samt anvendelse av saltene NO178108C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH304191 1991-10-16

Publications (4)

Publication Number Publication Date
NO924001D0 NO924001D0 (no) 1992-10-15
NO924001L NO924001L (no) 1993-04-19
NO178108B NO178108B (no) 1995-10-16
NO178108C true NO178108C (no) 1996-01-24

Family

ID=4247296

Family Applications (1)

Application Number Title Priority Date Filing Date
NO924001A NO178108C (no) 1991-10-16 1992-10-15 Salter av hydrazoner, farmasöytiske preparater inneholdende saltene samt anvendelse av saltene

Country Status (24)

Country Link
EP (1) EP0538193B1 (he)
JP (1) JP2788579B2 (he)
KR (1) KR100265307B1 (he)
AT (1) ATE145896T1 (he)
AU (1) AU658931B2 (he)
CA (1) CA2080545C (he)
CY (1) CY2127B1 (he)
CZ (1) CZ279601B6 (he)
DE (1) DE59207617D1 (he)
DK (1) DK0538193T3 (he)
ES (1) ES2095444T3 (he)
FI (1) FI112212B (he)
GR (1) GR3021903T3 (he)
HK (1) HK1005023A1 (he)
HU (1) HU226954B1 (he)
IL (1) IL103448A (he)
MX (1) MX9205934A (he)
NO (1) NO178108C (he)
NZ (1) NZ244725A (he)
RU (1) RU2081108C1 (he)
SA (1) SA93130417B1 (he)
SG (1) SG43185A1 (he)
SK (1) SK279938B6 (he)
ZA (1) ZA927957B (he)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2103166B1 (es) * 1992-08-26 1998-04-01 Ciba Geigy Ag Procedimiento para la obtencion de amidinohidrazonas biciclicas.
JP3989543B2 (ja) * 1995-01-26 2007-10-10 ノバルティス・アクチエンゲゼルシャフト イミダゾール誘導体、その製造およびs−アデノシルメチオニンデカルボキシラーゼ(=samdc)阻害剤としてのその使用
EP1483231A1 (de) * 2002-03-04 2004-12-08 Boehringer Ingelheim Pharma GmbH & Co.KG Neue salmeterol-zimtsäuresalze, verfahren zu deren herstellung und deren verwendung als arzneimittel
GT200600316A (es) * 2005-07-20 2007-04-02 Sales de 4-metilo-n-(3-(4-metilo-imidazol-1-ilo)-5-trifluorometilo-fenilo)-3-(4-piridina-3-ilo-pirimidina-2-iloamino)- benzamida.
EP1884515A1 (en) 2006-07-31 2008-02-06 Laboratorios del Dr. Esteve S.A. Substituted indanyl sulfonamide compounds, their preparation and use as medicaments

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU645799B2 (en) * 1990-05-07 1994-01-27 Novartis Ag Hydrazones

Also Published As

Publication number Publication date
DE59207617D1 (de) 1997-01-16
CA2080545A1 (en) 1993-04-17
CA2080545C (en) 2005-11-29
HU226954B1 (en) 2010-03-29
SA93130417B1 (ar) 2005-11-12
IL103448A0 (en) 1993-03-15
EP0538193A3 (en) 1993-06-16
MX9205934A (es) 1993-04-01
AU658931B2 (en) 1995-05-04
HUT63149A (en) 1993-07-28
IL103448A (he) 1998-01-04
FI924650A0 (fi) 1992-10-14
SG43185A1 (en) 1997-10-17
JP2788579B2 (ja) 1998-08-20
SK315292A3 (en) 1995-04-12
DK0538193T3 (da) 1996-12-23
EP0538193A2 (de) 1993-04-21
EP0538193B1 (de) 1996-12-04
CZ315292A3 (en) 1993-05-12
FI112212B (fi) 2003-11-14
HU9203234D0 (en) 1992-12-28
ES2095444T3 (es) 1997-02-16
KR930007896A (ko) 1993-05-20
NO178108B (no) 1995-10-16
CZ279601B6 (cs) 1995-05-17
HK1005023A1 (en) 1998-12-18
CY2127B1 (en) 2002-06-21
KR100265307B1 (ko) 2000-09-15
ZA927957B (en) 1993-04-26
ATE145896T1 (de) 1996-12-15
GR3021903T3 (en) 1997-03-31
NO924001D0 (no) 1992-10-15
JPH05239011A (ja) 1993-09-17
AU2704092A (en) 1993-04-22
NO924001L (no) 1993-04-19
FI924650A (fi) 1993-04-17
SK279938B6 (sk) 1999-06-11
NZ244725A (en) 1995-05-26
RU2081108C1 (ru) 1997-06-10

Similar Documents

Publication Publication Date Title
ES445075A1 (es) Un procedimiento para la preparacion de nuevos acidos fenoxi-alquil-carboxilicos.
DE3671370D1 (de) Zubereitungen zur behandlung von mycoplasmosen und bakteriellen erkrankungen bei gefluegel.
NO934501L (no) Karboksylsyrederivater, legemidler inneholdende disse forbindelser, og fremgangsmåte for deres fremstilling
ES8501362A1 (es) Un procedimiento para la preparacion de nuevos derivados arilfenolicos.
IE890177L (en) Piperidinyl derivatives
NO178108C (no) Salter av hydrazoner, farmasöytiske preparater inneholdende saltene samt anvendelse av saltene
DE69209128D1 (de) Verwendung von Indazol-Methoxyalkansäure zur Herstellung eines Arzneimittels zur Behandlung von Autoimmunkrankheiten
ES2109988T3 (es) Derivados cefalosporinicos.
GR78890B (he)
IE45665L (en) Acyl substituted benzimidazole-2-carboxylic acid¹derivatives.
SE8802814D0 (sv) Beredningar for lokal anvendning
NO855383L (no) Fremgangsmaate for fremstilling av piperazin-derivater.
SE8400629L (sv) Basiska oximetrar
HUP0204131A2 (hu) Szacharinszármazékok, mint orálisan aktív elasztáz inhibitorok, eljárás az előállításukra és ezeket tartalmazó gyógyszerkészítmények

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees